sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Cancer Biomarkers Market Size & Forecast

Download Free Sample View Report Summary
Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033
US$ 28.15 Billion
Market Size 2025 · Base Year
US$ 98.05 Billion
Projected Market Size by 2033
16.88%
CAGR · 2026–2033
Download Free Sample View Report Summary
sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608
SHARE
BMIPUB00036351 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
12
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)
10 +
Major Players
Major companies profiled including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, QIAGEN N.V., Illumina, Inc.
350
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Rising cancer prevalence

  • Precision oncology adoption

  • Advancing molecular diagnostics

Where Growth Opportunities Exist

Key Opportunities

  • Liquid biopsy expansion

  • AI-assisted biomarker discovery

  • Companion diagnostics growth

What Could Slow It Down

Market Restraints

  • High validation costs

  • Regulatory approval challenges

  • Limited clinical standardization

Market Segmentation

Coverage by Segment

Cancer Type

Breast Cancer
Lung Cancer
Colorectal Cancer

Biomarker Type

PSA
HER-2
EGFR

End User

Pharmaceutical & Biotechnology Companies
Diagnostics & Research Laboratories
Hospitals & Specialty Clinics
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
Abbott Laboratories
QIAGEN N.V.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Danaher Corporation
Siemens Healthineers AG
Becton, Dickinson and Company
What's Inside

Report Scope & Deliverables

Market Size 2025 US$ 28.15 Billion
Market Size 2033 US$ 98.05 Billion
CAGR 2026–2033 16.88%
Segments By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer)  |  By Biomarker Type (PSA, HER-2, EGFR)  |  By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics)
Geographies North America (US, Canada, Mexico)  ·  Europe (Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria)  ·  Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh)  ·  South and Central America (Brazil, Argentina, Chile, Colombia, Peru)  ·  Middle East and Africa (Saudi Arabia, United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00036351
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 350 pages of in-depth Cancer Biomarkers Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.

Request Customization Download Free Sample